Young American Indians, aged 15-39, had cholesterol levels more than two times higher than the general US population, according to new research published in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.
The researchers noted that previous research has estimated that approximately 25 percent of adolescents and approximately 30 percent of young adults in the US have high cholesterol.
“This is the first study of total cholesterol levels in American Indian adolescents and young adults, and we were surprised by the levels of high cholesterol, especially in adolescents,” said principal investigator Ying Zhang, M.D., Ph.D., an associate professor of biostatistics and director of the Center for American Indian Health Research at the University of Oklahoma Health Sciences Center in Oklahoma City.
“The high cholesterol in this population will likely lead to subtle damage in blood vessels and to premature heart disease. There is a need for care including early screening and treatment for high cholesterol levels,” Zhang said.
Researchers reviewed data from the Strong Heart Family Study — a study of risk factors for cardiovascular diseases among tribal communities in central Arizona, southwest Oklahoma, North Dakota and South Dakota. High cholesterol and its role in the development of heart disease and stroke was assessed among 1,440 American Indian teens and adults in the study.
What did the analysis find?
The prevalence of high cholesterol was 55.2 percent for American Indian adolescents, ages 15-19; 73.6 percent for American Indian young adults, ages 20-29; and 78 percent for American Indian adults, ages 30-39 years old.
Roughly 2.8 percent of all study participants had LDL-C, also known as “bad cholesterol,” higher than 160 mg/dL, which is above the recommended threshold for adults ages 20-39 years old.
During the follow-up examination in 2006-2009, 9.9 percent of participants had arterial plaque, 11 percent had plaque progression, and 9 percent had cardiovascular disease events. Arterial plaque are fatty deposits that accumulate on the inside of arteries, narrowing the vessels, which increase the risk of a number of health conditions, including peripheral artery disease, coronary heart disease and chronic kidney disease.
Participants with total cholesterol higher than 200 mg/dL had more than twice the risk of arterial plaque compared to participants with cholesterol lower than 200 mg/dL, as well as greater plaque buildup.
Despite the high prevalence of an imbalance of blood lipid levels (dyslipidemia) and the recommended cholesterol thresholds for intervention, none of the participants who were younger than age 20 were taking lipid-lowering medication during the study’s initial examination or 6-8 years later at the follow-up examination. (Dyslipidemia is an imbalance of blood lipid levels that can include high levels of low-density lipoproteins (“bad” cholesterol) or triglycerides (the most common type of fat in the body) or low levels of high-density lipoproteins (“good” cholesterol).)
It also found that 1.8 percent of the participants were taking lipid-lowering medications during the baseline exam, from 2001-2003. The use of lipid-lowering medication remained low at the follow-up examination, from 2006-2009, with 8 percent of participants taking medication to help lower cholesterol.
“It is our hope that our study’s results attract attention within the health care community,” Zhang said. “It would be beneficial for American Indian youth and young adults to get recommendations from their physicians about regularly checking cholesterol levels and following the AHA’s Life’s Essential 8 to help improve their cardiovascular health and prevent heart disease and stroke.”
Study details, background or design
The Strong Heart Study is focused on genetic and conventional cardiovascular risk factors among American Indians.
The study was conducted between 2001-2003 through 2020 and included American Indian teens and adults of ages 15-39 at the time of enrollment. Roughly 57 percent of the study’s participants self-identified as female, and 43 percent of participants self-identified as male.
Cardiovascular events were identified through 2020, with a median follow-up of 18.5 years.
Cholesterol levels were measured once, after a 12-hour fast at a follow-up exam.
Ultrasounds of the carotid artery were used to detect arterial plaque at enrollment and follow-up, with median follow-up of 5.5 years.
Study limitations include that the results may only be generalisable to other populations with a high prevalence of cardiometabolic risk factors, such as Type 2 diabetes, prediabetes, high cholesterol and abdominal obesity, similar to American Indian populations.
According to the Association’s 2020 scientific statement, Cardiovascular Health in American Indians and Alaska Natives, heart disease rates are noted as approximately 50 percent higher among the 5.2 million Americans who self-identify as American Indian and/or Alaska Native, compared to white Americans. In addition, Type 2 diabetes affects American Indian and Alaska Native adults at three times the rate of white adults in the US, and American Indian and Alaska Native adults develop cardiovascular diseases at younger ages in comparison to white adults.
Co-authors, disclosures and funding sources are listed in the manuscript. The Strong Heart Study has been funded by the National Heart, Lung, and Blood Institute, a division of the National Institutes of Health, for more than three decades.
